Febarbamate for the treatment of cranial nervous disorders and encephalic circulation and metabolism disorders
CA 2063736 A1 · Owner: Awaya, Akira · Inventors: Sasaki, Tadayuki; Awaya, Akira; Mizuchi, Akira
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The use of febarbamate or pharmaceutically acceptable salts for the improvement or treatment of diseases and disorders orginating in the breakdown or the degeneration of cranial central or, peripheral nerves; disorders and diseases related to the central or peripheral nervous systems; cerebrovascular disorders and neuron degeneration disorders; and/or disorders in encephalic circulation and metabolism is described. Preparation of suitable pharmaceutical compositions is also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 25, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 25, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 25, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.